In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

INO, Ikaria merge to form new critical care company

Executive Summary

A group of private investors led by New Mountain Capital, Arch Venture Partners, and Venrock Associates has merged critical care medicine developers Ikaria Inc. and INO Therapeutics LLC. Linde Group, the German industrial gas producer that owns INO, gets €380mm ($499mm) in cash plus a 17% equity stake in the new company, bringing the total deal value to $670mm.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies